Promising drug cocktail targets Hard-to-Treat cervical cancer
NCT ID NCT07363330
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase II trial tests a combination of two drugs—Utidelone and Toripalimab—in people with recurrent or metastatic cervical cancer that has stopped responding to standard treatments. All 32 participants will receive the same treatment, and doctors will monitor tumor shrinkage and side effects. The goal is to see if this combination can shrink tumors and improve outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Utidelone and Toripalimab
- What this could lead to
- If successful, this combination could offer a new treatment option for patients with recurrent or metastatic cervical cancer who have run out of standard therapies.
- What could go wrong
- This is a small, early-phase study with only 32 participants and no comparison group, so results may not apply broadly. Side effects from the drug combination are possible and will be closely monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Could a genetic marker guide future cancer therapies in taiwan?
- AI takes on cancer radiotherapy: can a computer plan treatment in minutes?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Can acupuncture help women regain bladder control after hysterectomy?